Back to Search
Start Over
Extending the scope of amantadine drug by incorporation of phenolic azo Schiff bases as potent selective inhibitors of carbonic anhydrase II, drug-likeness and binding analysis.
- Source :
-
Chemical biology & drug design [Chem Biol Drug Des] 2018 Sep; Vol. 92 (3), pp. 1692-1698. Date of Electronic Publication: 2018 Jun 26. - Publication Year :
- 2018
-
Abstract
- A series of Amantadine-based azo Schiff base dyes 6a-6e have been synthesized and characterized by <superscript>1</superscript> H NMR and <superscript>13</superscript> C NMR and evaluated for their in vitro carbonic anhydrase II inhibition activity and antioxidant activity. All of the synthesized showed excellent carbonic inhibition. Compound 6b was found to be the most potent derivative in the series, and the IC <subscript>50</subscript> of 6b was found to be 0.0849 ± 0.00245 μm (standard Acetazolamide IC <subscript>50</subscript>  = 0.9975 ± 0.049 μm). The binding interactions of the most active analogs were confirmed through molecular docking studies. Docking studies showed 6b is interacting by making two hydrogen bonds w at His93 and Ser1 residues, respectively. All compounds showed a good drug score and followed Lipinski's rule. In summary, our studies have shown that these amantadine-derived phenolic azo Schiff base derivatives are a new class of carbonic anhydrase II inhibitors.<br /> (© 2018 John Wiley & Sons A/S.)
- Subjects :
- Amantadine metabolism
Binding Sites
Carbonic Anhydrase II metabolism
Carbonic Anhydrase Inhibitors metabolism
Catalytic Domain
Humans
Hydrogen Bonding
Molecular Docking Simulation
Protein Binding
Protein Isoforms antagonists & inhibitors
Protein Isoforms metabolism
Schiff Bases metabolism
Thermodynamics
Amantadine chemistry
Carbonic Anhydrase II antagonists & inhibitors
Carbonic Anhydrase Inhibitors chemistry
Phenols chemistry
Schiff Bases chemistry
Subjects
Details
- Language :
- English
- ISSN :
- 1747-0285
- Volume :
- 92
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Chemical biology & drug design
- Publication Type :
- Academic Journal
- Accession number :
- 29770563
- Full Text :
- https://doi.org/10.1111/cbdd.13335